You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
|
---|---|
Published in |
Molecular Cancer, July 2009
|
DOI | 10.1186/1476-4598-8-47 |
Pubmed ID | |
Authors |
Shizuko Sei, Jodie K Mussio, Quan-en Yang, Kunio Nagashima, Ralph E Parchment, Matthew C Coffey, Robert H Shoemaker, Joseph E Tomaszewski |
Abstract |
Reovirus type 3 Dearing strain (ReoT3D) has an inherent propensity to preferentially infect and destroy cancer cells. The oncolytic activity of ReoT3D as a single agent has been demonstrated in vitro and in vivo against various cancers, including colon, pancreatic, ovarian and breast cancers. Its human safety and potential efficacy are currently being investigated in early clinical trials. In this study, we investigated the in vitro combination effects of ReoT3D and chemotherapeutic agents against human non-small cell lung cancer (NSCLC). |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | 2% |
Netherlands | 1 | 2% |
Australia | 1 | 2% |
India | 1 | 2% |
United Kingdom | 1 | 2% |
Unknown | 57 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 22 | 35% |
Student > Bachelor | 9 | 15% |
Student > Ph. D. Student | 8 | 13% |
Student > Master | 4 | 6% |
Student > Doctoral Student | 3 | 5% |
Other | 8 | 13% |
Unknown | 8 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 21 | 34% |
Medicine and Dentistry | 11 | 18% |
Biochemistry, Genetics and Molecular Biology | 6 | 10% |
Immunology and Microbiology | 3 | 5% |
Business, Management and Accounting | 2 | 3% |
Other | 4 | 6% |
Unknown | 15 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2017.
All research outputs
#5,447,195
of 25,374,917 outputs
Outputs from Molecular Cancer
#443
of 1,918 outputs
Outputs of similar age
#22,926
of 122,368 outputs
Outputs of similar age from Molecular Cancer
#3
of 15 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,918 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,368 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.